{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:17Z","timestamp":1794558257172,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014939","name":"Church and Dwight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nasal congestion associated with the common cold is a frequent source of distress in infants and toddlers. While hypertonic seawater solutions offer a physiological mechanism for decongestion via osmosis, robust clinical evidence supporting their use as an adjunct to standard care in this specific pediatric population is essential to validate their therapeutic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of a hypertonic seawater nasal spray enriched with copper and manganese combined with standard of care compared to standard of care alone in alleviating nasal congestion, improving sleep quality, and accelerating symptom recovery in infants and toddlers aged 3\u201348\u00a0months experiencing the common cold without high fever (excluding acute rhinosinusitis).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a randomized, open-label, controlled parallel study, 220 participants received standard care (which included ample hydration, at-home rest, and the use of paracetamol as needed) with or without the nasal spray. Outcomes, including symptom severity, recovery rate, sleep quality, secondary infections, and caregiver satisfaction, were assessed via questionnaires over 10\u00a0days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants using the nasal spray experienced a significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) reduction in nasal congestion from the evening of Day 0 through Day 5, with immediate symptom relief observed within 5\u201315\u00a0min of application. By Day 10, recovery rates were higher in the nasal spray group (75.3% vs. 58.5%). Improvements in cough and runny nose severity were significant, though minimal effects were noted for other symptoms. Sleep quality and secondary infection rates were comparable between groups. Caregivers expressed high satisfaction, with 93.6% willing to use the product again. No adverse events were linked to the nasal spray.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The hypertonic seawater solution nasal spray is a safe and effective adjunct to standard care, providing rapid relief of nasal congestion and improving cold recovery rates in young children. Trial registered at ClinicalTrials.gov: NCT05365789 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/search?cond=NCT05365789\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/search?cond=NCT05365789<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00405-026-10615-z","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:26:53Z","timestamp":1789536413000},"page":"7945-7957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of seawater-based nasal irrigation on nasal congestion in infants and toddlers with common cold: a randomized controlled trial"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2154-5651","authenticated-orcid":false,"given":"Oliver","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Constance","family":"Prime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vanderzande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marita","family":"Alegre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rynkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anetta","family":"Karpi\u0144ska-Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annahita","family":"Ghassemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"10615_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archinte.163.4.487","volume":"163","author":"AM Fendrick","year":"2003","unstructured":"Fendrick AM, Monto AS, Nightengale B et al (2003) The economic burden of non\u2013influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163:487\u2013494. https:\/\/doi.org\/10.1001\/archinte.163.4.487","journal-title":"Arch Intern Med"},{"key":"10615_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s1526-0542(03)00031-9","volume":"4","author":"P Mackie","year":"2003","unstructured":"Mackie P (2003) The classification of viruses infecting the respiratory tract. Paediatr Respir Rev 4:84\u201390. https:\/\/doi.org\/10.1016\/s1526-0542(03)00031-9","journal-title":"Paediatr Respir Rev"},{"key":"10615_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0140-6736(03)12162-9","volume":"361","author":"T Heikkinen","year":"2003","unstructured":"Heikkinen T, J\u00e4rvinen A (2003) The common cold. Lancet 361:51\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(03)12162-9","journal-title":"Lancet"},{"key":"10615_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/archpedi.156.2.121","volume":"156","author":"TM Ball","year":"2002","unstructured":"Ball TM, Holberg CJ, Aldous MB et al (2002) Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 156:121\u2013126. https:\/\/doi.org\/10.1001\/archpedi.156.2.121","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10615_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7027","volume":"347","author":"M Thompson","year":"2013","unstructured":"Thompson M, Vodicka TA, Blair PS et al (2013) Duration of symptoms of respiratory tract infections in children: systematic review. BMJ 347:f7027. https:\/\/doi.org\/10.1136\/bmj.f7027","journal-title":"BMJ"},{"key":"10615_CR6","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1542\/peds.108.3.e52","volume":"108","author":"VL Gunn","year":"2001","unstructured":"Gunn VL, Taha SH, Liebelt EL et al (2001) Toxicity of over-the-counter cough and cold medications. Pediatrics 108:e52\u2013e52. https:\/\/doi.org\/10.1542\/peds.108.3.e52","journal-title":"Pediatrics"},{"key":"10615_CR7","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1542\/peds.2008-0854","volume":"123","author":"N Lokker","year":"2009","unstructured":"Lokker N, Sanders L, Perrin EM et al (2009) Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics 123:1464\u20131471. https:\/\/doi.org\/10.1542\/peds.2008-0854","journal-title":"Pediatrics"},{"key":"10615_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archoto.2007.19","volume":"134","author":"I \u0160lapak","year":"2008","unstructured":"\u0160lapak I, Skoup\u00e1 J, Strnad P et al (2008) Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 134:67\u201374. https:\/\/doi.org\/10.1001\/archoto.2007.19","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10615_CR9","doi-asserted-by":"publisher","unstructured":"Li CL, Lin HC, Lin CY et al (2019) Effectiveness of hypertonic saline nasal irrigation for alleviating allergic rhinitis in children: a systematic review and meta-analysis. J Clin Med 8:20190109. https:\/\/doi.org\/10.3390\/jcm8010064","DOI":"10.3390\/jcm8010064"},{"key":"10615_CR10","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332. https:\/\/doi.org\/10.1136\/bmj.c332","journal-title":"BMJ"},{"key":"10615_CR11","unstructured":"Food and Drug Administration (2005) Reviewer guidance: conducting a clinical safety review of a new product application and preparing a report on the review. Federal Register 70:8381. https:\/\/www.govinfo.gov\/content\/pkg\/FR-2005-02-18\/pdf\/05-3181.pdf"},{"key":"10615_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-12-147","volume":"12","author":"T Fazekas","year":"2012","unstructured":"Fazekas T, Eickhoff P, Pruckner N et al (2012) Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med 12:147. https:\/\/doi.org\/10.1186\/1472-6882-12-147","journal-title":"BMC Complement Altern Med"},{"key":"10615_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-124","volume":"14","author":"M Ludwig","year":"2013","unstructured":"Ludwig M, Enzenhofer E, Schneider S et al (2013) Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial. Respir Res 14:124. https:\/\/doi.org\/10.1186\/1465-9921-14-124","journal-title":"Respir Res"},{"key":"10615_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/md20050330","volume":"20","author":"D \u0160tanfel","year":"2022","unstructured":"\u0160tanfel D, Kalogjera L, Ryazantsev SV et al (2022) The role of seawater and saline solutions in treatment of upper respiratory conditions. Mar Drugs 20:330. https:\/\/doi.org\/10.3390\/md20050330","journal-title":"Mar Drugs"},{"key":"10615_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75464","volume":"16","author":"M Cruz","year":"2024","unstructured":"Cruz M, Roteia C, Marques Ferreira A et al (2024) Nasal irrigation with saline solution for pediatric acute upper respiratory infections: a systematic review. Cureus 16:e75464. https:\/\/doi.org\/10.7759\/cureus.75464","journal-title":"Cureus"},{"key":"10615_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3906\/sag-1507-18","volume":"46","author":"T K\u00f6ksal","year":"2016","unstructured":"K\u00f6ksal T, Cizmeci MN, Bozkaya D et al (2016) Comparison between the use of saline and seawater for nasal obstruction in children under 2 years of age with acute upper respiratory infection. Turk J Med Sci 46:1004\u20131013. https:\/\/doi.org\/10.3906\/sag-1507-18","journal-title":"Turk J Med Sci"},{"key":"10615_CR17","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.ijporl.2009.09.001","volume":"73","author":"Y-H Wang","year":"2009","unstructured":"Wang Y-H, Yang C-P, Ku M-S et al (2009) Efficacy of nasal irrigation in the treatment of acute sinusitis in children. Int J Pediatr Otorhinolaryngol 73:1696\u20131701. https:\/\/doi.org\/10.1016\/j.ijporl.2009.09.001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10615_CR18","doi-asserted-by":"crossref","unstructured":"Hendeles L (1993) Selecting a decongestant. Pharmacotherapy 13:129S\u2013134S; discussion 143S\u2013146S","DOI":"10.1002\/j.1875-9114.1993.tb02781.x"},{"key":"10615_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijporl.2017.04.040","volume":"98","author":"N Guti\u00e9rrez-Cardona","year":"2017","unstructured":"Guti\u00e9rrez-Cardona N, Sands P, Roberts G et al (2017) The acceptability and tolerability of nasal douching in children with allergic rhinitis: a systematic review. Int J Pediatr Otorhinolaryngol 98:126\u2013135. https:\/\/doi.org\/10.1016\/j.ijporl.2017.04.040","journal-title":"Int J Pediatr Otorhinolaryngol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10615-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:07:22Z","timestamp":1794557242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10615"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10615-z","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Bioethics Committee of the Regional Chamber of Physicians (Gda\u0144sk, Poland). This study was conducted per the ethical principles initially outlined in the Declaration of Helsinki (1964) and according to EN ISO standard 14155:2020 and EU regulation 2017\/745 on medical devices and complies with local regulatory requirements.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed informed consent and authorization for the use of protected health information were provided by each participant\u2019s parents\/legal guardians before implementing any protocol-specific procedures.","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"St\u00e9rimar\u2122 is a registered trademark of Sofibel S.A.S, a subsidiary of Church & Dwight Ltd. OC is a Senior Clinical Manager at Church & Dwight Co., Inc. CP is an R&D Manager at Church & Dwight Co., Inc. WH is a Statistician at Church & Dwight Co., Inc. TV is a R&D project leader at Church & Dwight Co., Inc. MA is an R&D Senior Director at Church & Dwight Co., Inc. AR and AK were the study investigators at Eurofins have no conflict of interest to declare. AG is a Senior Director for Global Safety and Clinical at Church & Dwight Co., Inc.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}